Skip to main content
Clinical Trials/JPRN-UMIN000027255
JPRN-UMIN000027255
Recruiting
未知

Efficacy and safety of dulaglutide in the treatment of type 2 diabetes - Efficacy and safety of dulaglutide in the treatment of type 2 diabetes

Department of nephrology, Matsunami general hospital0 sites30 target enrollmentMay 6, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 2 diabetes mellitus patients
Sponsor
Department of nephrology, Matsunami general hospital
Enrollment
30
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 6, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of nephrology, Matsunami general hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients with gastrointestinal bleeding, malignant tumor, liver cirrhosis, and thyroid function abnormalities.

Outcomes

Primary Outcomes

Not specified

Similar Trials